[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO1999020305A8 - Veterinary vaccines - Google Patents

Veterinary vaccines

Info

Publication number
WO1999020305A8
WO1999020305A8 PCT/AU1998/000865 AU9800865W WO9920305A8 WO 1999020305 A8 WO1999020305 A8 WO 1999020305A8 AU 9800865 W AU9800865 W AU 9800865W WO 9920305 A8 WO9920305 A8 WO 9920305A8
Authority
WO
WIPO (PCT)
Prior art keywords
veterinary vaccines
vaccines
veterinary
lambs
sheep
Prior art date
Application number
PCT/AU1998/000865
Other languages
French (fr)
Other versions
WO1999020305A1 (en
Inventor
Richard Buchta
Christopher Leigh Schwartzkoff
Philip Ralph Lehrbach
Original Assignee
Fort Dodge Australia Pty Limit
Richard Buchta
Christopher Leigh Schwartzkoff
Philip Ralph Lehrbach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9722035.4A external-priority patent/GB9722035D0/en
Application filed by Fort Dodge Australia Pty Limit, Richard Buchta, Christopher Leigh Schwartzkoff, Philip Ralph Lehrbach filed Critical Fort Dodge Australia Pty Limit
Priority to AU96161/98A priority Critical patent/AU753804B2/en
Priority to US09/509,961 priority patent/US6524592B2/en
Priority to PCT/AU1998/000865 priority patent/WO1999020305A1/en
Priority to NZ503636A priority patent/NZ503636A/en
Priority to EP98949828A priority patent/EP1023083A4/en
Priority to CA2307000A priority patent/CA2307000C/en
Publication of WO1999020305A1 publication Critical patent/WO1999020305A1/en
Publication of WO1999020305A8 publication Critical patent/WO1999020305A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to vaccines which are suitable for the prevention of clostridial diseases of sheep (and lambs), providing an effective immunity for up to a year or more following a single injection or dose.
PCT/AU1998/000865 1997-10-17 1998-10-16 Veterinary vaccines WO1999020305A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU96161/98A AU753804B2 (en) 1997-10-17 1998-10-16 Veterinary vaccines
US09/509,961 US6524592B2 (en) 1997-10-17 1998-10-16 Veterinary vaccines
PCT/AU1998/000865 WO1999020305A1 (en) 1997-10-17 1998-10-16 Veterinary vaccines
NZ503636A NZ503636A (en) 1997-10-17 1998-10-16 Vaccines for the prevention of clostridial diseases of sheep that provide effective immunity for up to a year or more from a single dose
EP98949828A EP1023083A4 (en) 1997-10-17 1998-10-16 Veterinary vaccines
CA2307000A CA2307000C (en) 1997-10-17 1998-10-16 Veterinary vaccines

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9722035.4 1997-10-17
GBGB9722035.4A GB9722035D0 (en) 1997-10-17 1997-10-17 Veterinary vaccines
PCT/AU1998/000865 WO1999020305A1 (en) 1997-10-17 1998-10-16 Veterinary vaccines

Publications (2)

Publication Number Publication Date
WO1999020305A1 WO1999020305A1 (en) 1999-04-29
WO1999020305A8 true WO1999020305A8 (en) 1999-07-08

Family

ID=25641911

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1998/000865 WO1999020305A1 (en) 1997-10-17 1998-10-16 Veterinary vaccines

Country Status (5)

Country Link
EP (1) EP1023083A4 (en)
AU (1) AU753804B2 (en)
CA (1) CA2307000C (en)
NZ (1) NZ503636A (en)
WO (1) WO1999020305A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824279B1 (en) * 2001-05-04 2004-05-28 Seppic Sa CONCENTRATED W / O EMULSION
FR2824269B1 (en) * 2001-09-03 2012-03-02 Seppic Sa ADJUVANT COMPOSITION CONSISTING OF 1% TO 15% OF SURFACTANTS AT GLOBAL HLB INCLUDING BETWEEN 5 AND 8 AND 85% TO 99% OF BODY FATS
NZ569627A (en) * 2005-12-15 2012-01-12 Hancroft Pty Ltd The use of virginiamycin for preventing reduced feed intake and treating laminitis, fermentative acidosis, equine grass sickness and pulpy kidney
FR2903602B1 (en) * 2006-07-12 2012-10-26 Seppic Sa INJECTABLE FORMULATION WITH PROLONGED RELEASE OF ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME
FR2922767B1 (en) 2007-10-24 2009-12-18 Seppic Sa PROCESS FOR PREPARING A VACCINE COMPOSITION COMPRISING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT
CN106177935A (en) * 2016-08-19 2016-12-07 齐鲁动物保健品有限公司 A kind of ruminant clostridial disease tetrad inactivated vaccine and preparation method thereof
GB201718251D0 (en) * 2017-11-03 2017-12-20 Univ Sydney Vaccine Compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128325A (en) * 1964-11-11 1968-09-25 Wellcome Found Improvements in water-in-oil emulsion vaccines
US3843451A (en) * 1970-08-20 1974-10-22 Burroughs Wellcome Co Microorganism production
FR2649012B1 (en) * 1989-07-03 1991-10-25 Seppic Sa INJECTABLE MULTIPHASIC EMULSIONS
FR2717694B1 (en) * 1994-03-22 1996-05-03 Seppic Sa A composition comprising a recombinant plasmid and its uses as a vaccine and medicament.
DK0781559T3 (en) * 1995-11-30 2007-02-26 Chemo Sero Therapeut Res Inst Oil adjuvant vaccine and method for making the same
GB9626865D0 (en) * 1996-12-24 1997-02-12 Cyanamid Websters Pty Limited Veterinary vaccines

Also Published As

Publication number Publication date
WO1999020305A1 (en) 1999-04-29
AU9616198A (en) 1999-05-10
EP1023083A4 (en) 2006-06-14
NZ503636A (en) 2002-05-31
EP1023083A1 (en) 2000-08-02
CA2307000A1 (en) 1999-04-29
AU753804B2 (en) 2002-10-31
CA2307000C (en) 2011-01-04

Similar Documents

Publication Publication Date Title
GB2322801B (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
ZA975943B (en) Aqueous formulations of peptides.
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
ZA98361B (en) Hypodermic injection system.
DE69021387D1 (en) MEDICAL AEROSOL FORMULATIONS.
ZA969722B (en) Pharmaceutical formulations.
EP0671902A4 (en) -i(CLOSTRIDIAL) TOXIN DISEASE THERAPY.
AU3699397A (en) Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
EP0680337A4 (en) Methods and compositions for the direct concentrated delivery of passive immunity.
EP1072254A4 (en) Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
NO902441D0 (en) Aroma delivery system, as well as chewing gum mixture.
EP0640097A4 (en) Compositions and methods for vaccination against coronaviruses.
DZ2283A1 (en) Vaccine composition.
WO1999020305A8 (en) Veterinary vaccines
WO1999002143A3 (en) Medicament comprising adenosine
BR9608255A (en) Transdermal therapeutic system (stt) for testosterone administration
WO1998040097A3 (en) Bovine respiratory and enteric coronavirus as a vaccine
WO1999057278A3 (en) IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
WO1999058145A3 (en) Immunomodulators for vaccines
ZA962461B (en) Low dose ridogrel formulations.
ES2184987T3 (en) SOLID ADMINISTRATION FORMS OF INSTANT LIBERATION AND PROCEDURE FOR PREPARATION.
ZA975586B (en) Recombinant vaccine for diseases caused by encapsulated organisms.
EP0663209A3 (en) Medicament for inhibiting the effects of amyloidogenic proteins.
DE69513760D1 (en) Immunizing composition based on Helicobacter pylori catalase
AP2000001746A0 (en) Anti- first-pass effect compounds.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 503636

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1998949828

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2307000

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2307000

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 96161/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 09509961

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1998949828

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 96161/98

Country of ref document: AU